Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mohs Surgery Effective for Invasive Melanomas

Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al

Mohs micrographic surgery is an effective treatment method for invasive melanoma, as evidenced by low recurrence rates and high rates of disease-free survival, according to a recent study. A retrospective cohort study evaluated 123 melanomas excised using Mohs micrographic surgery (MMS) with MART-1 immunostain. Local recurrence, metastasis, overall survival, and disease-free survival rates were calculated. These were compared with historical controls. Among included patients, 78 were men (63%) and 45 were women (37%), with a mean age of 66.48 years. They found:

  • Mean follow-up time was 1,273 days (3.49 years).
  • Local recurrence was identified in 2/123 (1.63%) lesions.
  • Local recurrence was identified in 1/70 (1.43%) of head and neck cases.
  • Tumor location was head and neck in 70 lesions (56.9%).
  • Overall survival was 95.12% and disease-specific survival was 100%.

Citation:

Degesys CA, Powell HB, Hsia L-L B, Merritt BG. Outcomes for invasive melanomas treated with Mohs micrographic surgery: A retrospective cohort study. [Published online ahead of print September 7, 2018]. Dermatolog Surg. doi:10.1097/DSS.0000000000001658.

This Week's Must Reads

Link Between AD and Autoimmune Disorders, J Am Acad Dermatol; ePub 2018 Oct 1; Narla, et al

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Prevalence of Acne Vulgaris Among Patients with HS, J Am Acad Dermatol; ePub 2018 Oct 1; Wertenteil, et al

Skin Disease Epidemiology in a Diverse Population, J Drugs Dermatol; 2018 Oct; Gaulding, et al

Psoriasis Treatment Receives Tentative FDA Approval, Bausch Heath news release; 2018 Oct 8

Must Reads in Melanoma

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Follicular Involvement Frequent in Lentigo Maligna, J Am Acad Dermatol; ePub 2018 Sep 26; Connolly, et al

Sentinel Lymph Node Positivity Markers in Melanoma, J Am Acad Dermatol; ePub 2018 Sep 18; Conic, et al

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Mohs Surgery Effective for Invasive Melanomas, Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al